title: [Malignant gliomas--radiotherapy].
abstract: Postoperative radiotherapy is the treatment of choice for high grade gliomas and glioblastomas. The goal of the adjuvant radiotherapy is to improve local control and long term survival. The benefit of re-irradiation for recurrent or progressive glioma is controversial. The therapeutic benefit of any radiotherapy intervention must be balanced by the risk of neurotoxicity and its impact on quality of life.
authors.affiliation: Institut für Radioonkologie, Kaiser Franz Josef Spital, SMZ-Süd, Kundratstrasse 3, 1100 Vienna, Austria. annemarie.schratter-sehn@wienkav.at
authors.forename: Annemarie
authors.initials: A
authors.lastname: Schratter-Sehn
mesh_terms: D001921:Brain / Q000528:radiation effects; D001932:Brain Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D016371:Cranial Irradiation / Q000379:methods*; D005909:Glioblastoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D005910:Glioma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D011832:Radiation Injuries / Q000517:prevention & control; D018714:Radiotherapy, Adjuvant; D019233:Retreatment